Cleared Traditional

K182367 - DIASAFEplusUS (FDA 510(k) Clearance)

Jan 2019
Decision
132d
Days
Class 2
Risk

K182367 is an FDA 510(k) clearance for the DIASAFEplusUS. This device is classified as a Subsystem, Water Purification (Class II - Special Controls, product code FIP).

Submitted by Fresenius Medical Care Renal Therapies Group, LLC (Waltham, US). The FDA issued a Cleared decision on January 10, 2019, 132 days after receiving the submission on August 31, 2018.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5665.

Submission Details

510(k) Number K182367 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 31, 2018
Decision Date January 10, 2019
Days to Decision 132 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code FIP — Subsystem, Water Purification
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5665

Similar Devices — FIP Subsystem, Water Purification

AquaC UNO H
K250471 · Fresenius Medical Care Renal Therapies Group, LLC · Nov 2025
DIASAFEplusUS (F00013010)
K251851 · Fresenius Medical Care Renal Therapies Group, LLC · Oct 2025
AquaA
K252181 · Fresenius Medical Care North America · Sep 2025
AquaBplus
K232953 · Fresenius Medical Care Renal Therapies Group, LLC · Jun 2024
AQUAbase nX
K223479 · B.Braun Medical, Inc. · Aug 2023
U9000 Plus Ultrafilter
K211035 · Baxter Healthcare Corporation · Oct 2021